Diclofenac Sodium Misoprostol Tablet, Delayed Release
Product Images NDC 75834-264

2 FDA label images from Nivagen Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium Misoprostol (NDC 75834-264). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

50-200mcg60c.jpg (50 200mcg60c)

50-200mcg60c.jpg (50 200mcg60c)
Label for Diclofenac Sodium and Misoprostol Delayed-Release Tablets, USP, 50 mg/200 mcg strength, in a bottle containing 60 tablets. Manufactured by Nivagen Pharmaceuticals, Inc. The label includes a pregnancy warning, storage instructions, and pharmacist dispensing guidance. The NDC is 75834-264-60.*
FDA Label Image

75-200mcg60c.jpg (75 200mcg60c)

75-200mcg60c.jpg (75 200mcg60c)
Label for Diclofenac Sodium and Misoprostol Delayed-Release Tablets USP, 75 mg/200 mcg, containing 60 tablets. The label includes a pregnancy warning, storage instructions at 20° to 25°C, and directions to see prescribing information for dosage and use. Manufactured for Nivagen Pharmaceuticals, Inc., Sacramento, CA, with the product made in Taiwan.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.